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Abstract
Understanding the pathogenesis in the early stages of late-onset Alzheimer’s
disease (LOAD) can help in gaining important mechanistic insights into this
devastating neurodegenerative disorder. Alzheimer’s disease (AD) is char-
acterised by extensive cell death with disease progression. In this paper
laser capture microdissection (LCM) based gene expression profiling, which
is able to profile gene expression in a single cell type, is employed to analyse
the gene expression regulation of incipient AD. Our analysis shows that LCM
based gene expression profiling of neurons has a critical advantage over the
conventional gene expression profiling method which uses samples of mixed
cell types and does not account for cell loss. A natural question that arises
in this situation is how can we say that a gene is ”down-regulated” when it
just may not be present due to the absence of cells? Our investigation on
expression regulation also resulted in 1633 significant genes, from which we
identified 15 DNA repair genes that had elevated or lowered levels of mRNA
expression. Many key players involved in the defense against DNA damage
were present in this list, and many genes were involved in the base-excision
repair pathway. Our results indicate that the base excision repair pathway,
a predominant pathway in neurons, fails to handle the DNA damage in an
efficient manner and is a compelling explanation for many of the pathological
features of LOAD.
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Introduction
Late-onset Alzheimer’s disease (LOAD) is a complex progressive neurodegenerative disor-
der of the brain and is the commonest form of dementia. Advancing age is the major
contributing factor for increased susceptibility to Alzheimer’s Disease (AD) and the old are
the fastest-growing segment of the United States population and have the highest prevalence
of dementia [1]. Early diagnosis of AD can help in effective treatment strategies. Therefore,
studying the pathogenesis of incipient AD is very crucial.
Pathologically AD is characterised by the presence of neurofibrillary tangles (NFT) in
the neurons of the cerebral cortex and hippocampus. Six stages of AD disease propagation
have been distinguished: transentorhinal stages I-II (clinically silent cases), limbic stages III-
IV (incipient AD) and neocortical stages V-VI (fully developed AD) [2]. The neurofibrillary
pathology begins at the transentorhinal and entorhinal cortices and then proceeds to the
hippocampus [3]. AD is also characterised by marked neuronal cell loss. In particular
cell loss has been correlated with the amount of NFT but not with age or β/A4-amyloid
deposition [4]. Furthermore, it has been shown that neuronal cell loss is greater than volume
loss (51% and 25%, respectively) between stages I and V in the hippocampus [2].
Tissues are structures with many different cell types. In disease pathologies, the diseased
cells of interest are surrounded by these heterogeneous tissue elements. Cells that are
primarily affected in a disease and depict molecular changes due to disease progression may
constitute a very small fraction of the volume of the tissue biopsy sample. In the last few
years, there have been many gene expression studies related to AD. The majority of them
have used samples obtained via regular dissection from affected brain regions. Considering
that there is neuronal cell loss (even greater than volume loss) in neurodegenerative diseases
and the heterogeneity of samples due to regular dissection, interpretation of gene expression
results may be difficult and somewhat ambiguous. Variability in gene expression may not be
due to AD but rather resulting from cellular heterogeneity of brain tissues. Furthermore,
since there is cell loss, how can it be concluded that the decrease or increase in mRNA
expression levels is actually a “down-regulation” or “up-regulation” when it can also be
due to the absence or presence of cells? Laser Capture Microdissection (LCM), which
was introduced by the NIH in 1996 [5], is a method for procuring pure cells from specific
microscopic regions of tissue sections. In this procedure, the kind and number of cells can
be controlled so that one can compare the mRNA expression level of a gene in the same
number of cells of the same type across different samples.
We have two main objectives in this study - the first is to compare Blalock et al.’s [6]
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AD gene expression dataset obtained via regular tissue dissection with the LCM data ob-
tained by Dunckley et al. [7] to distinguish the power of the dataset and interpretability of
results. We perform the comparison by analysing the results of two differentially expressed
gene selection methods - SAM [8] and Limma [9]- when applied to the two datasets. As
microdissection is expensive and requires highly specialised technical ability, it is worth-
while to examine the difference, if any, between the two datasets obtained via these two
tissue dissection methods. Secondly, although it has been suggested that DNA repair is
compromised in AD, it has not been studied via microarray analysis in proper detail. In
view of this aspect, the second aim of the present study is to mine Dunckley et al.’s data,
and examine the DNA repair capacity in incipient AD. We feel that this dataset has not
been thoroughly analysed by Dunckley et al. and a lot of potentially new knowledge re-
garding LOAD is present in the data. We want to investigate whether defects in the DNA
repair pathways contribute to cell death that is typical in AD. In this article we report the
activity of 15 DNA repair genes that were up or down-regulated in the AD individuals. Our
analysis indicates a major disruption of the base-excision repair pathway as many of the
significant genes identified were key players of this pathway.
To the best of our knowledge, this is the first study that compares the power of regular
dissection and LCM-based gene expression profiling methods in a critical human disease.
This is also the first study that has focused on the expression levels of DNA repair genes in
LOAD affected individuals via microarray analysis. The investigation of genes perturbed in
the DNA repair pathways via microarray analysis is important as it provides differentially
expressed genes that are significant from a systems biology perspective and not in isolation
from other genes. A gene may be significant when considered separately from the rest of
the genes, however, when its effects are inspected taking all the other genes’ activity into
account, it may or may not be significantly differentially expressed.
Results and Discussion
We used SAM [8] and Limma [9] to identify differentially expressed genes (See Methods).
Comparison of laser capture microdissection and regular dissection based
gene expression datasets
Table 1 shows the number of significant genes obtained from Blalock et al.’s and Dunckley
et al.’s datasets using SAM and Limma. The false discovery rates (FDRs) shown in this
table are the lowest FDRs achieved by each dataset using each of the 2 gene selection
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methods. Although at a FDR of 1.1E-09 Limma gives 2 genes, at a FDR of 0.10%, Limma
outputs 4372 significant genes. It is evident from these results that Dunckley et al.’s data
provides a large number of differentially expressed transcripts when compared to Blalock et
al.’s data, at reasonably low FDRs. These results clearly show the “richness” of Dunckley
et al.’s dataset which was generated from microdissected samples.
In SAM, while the list of 1663 genes had up and down regulated genes, the list of 12
genes from Blalock et al.’s data only consisted of genes with decreased levels of expression.
Other than the problem of providing few genes with low FDR in Blalock et al.’s data, there
is also the issue with interpreting the 12 genes. The lowered levels of expression could
be due to two reasons - (1)down-regulation of these genes in Braak stage V AD or (2)the
absence of cells due to cell death resulting in no mRNA levels to measure. This dilemma is
eliminated in Dunckley et al.’s data as cells of the same type, i.e. neurons, were obtained
via LCM [7]. This means that one can compare the mRNA expression levels in a constant
number of living cells across all samples. Hence, if a gene has lowered level of expression,
it means it is down-regulated.
Another issue with Blalock et al.’s data is that it neither contains samples of AD with
Braak stage III, which is incipient AD, nor is it taken from the entorhinal cortex, where AD
pathology occurs first [10, 2]. Hence, analysis of Blalock et al’s data may not be appropriate
for studying the pathogenesis of incipient AD. As our aim is to examine expression changes
in incipient AD, we further analyse the significant genes list obtained from Dunckley et al.’s
data by SAM. We arbitrarily chose to analyse SAM’s results over Limma’s, although we
believe that we would find similar results using Limma.
We believe that the aforementioned issues have been previously overlooked.
Analysis of DNA repair genes in incipient AD - Results from Dunckley
et al.’s LCM dataset
EASE (http://niaid.abcc.ncifcrf.gov/home.jsp) was used to identify statistically significant
biological processes present in the list of significant genes identified from Dunckley et al.’s
dataset using SAM (See Methods). As Dunckley et al.’s dataset was generated from a 1000
neurons procured from each of the 33 samples (See Methods), the majority of biological
processes are related to functions in neurons (see Table 2). One of the statistically significant
biological process categories is DNA repair. Since the study of DNA repair in incipient AD
is still in its nascent stage and has not been investigated in depth, we decided to inspect
the set of genes involved in the defense against DNA damage.
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Genomes are subject to damage by chemical and physical agents in the environment and
by free radicals or alkylating agents endogenously generated during metabolism. Damage
can result from hydrolysis, deamination, alkylation, and oxidation, all of which are capable
of causing a modification in one or more bases in a DNA sequence. Mature neurons in
the mammalian brain cannot divide and are highly metabolically active. Due to the high
oxygen consumption rate by the brain, reactive oxygen species (ROS) can contribute to
neuronal damage. Oxidative stress in neurons in human neurodegenerative diseases such
as AD has been documented in previous reports [11, 12]. ROS attack of DNA can lead to
DNA–DNA and DNA–protein cross linking, re-entry into cell-cycle by mature neurons, DNA
strand breaks, production of oxidized base adducts, modification of DNA bases leading to
problems in DNA replication and altered protein synthesis, and sister chromatid exchange
and translocation in nuclear DNA [12]. The maintenance of genome integrity is essential
and particularly important to neurons as they are among the longest living cells in the body.
Accumulation of mutations and decline in DNA repair during disease progression can lead to
cancerous conditions and/or cell death. In response to DNA damage, cells activate multiple
signalling pathways, leading to the accumulation of proteins in complex multisubunit nuclear
foci, that represent sites of DNA replication arrest or sites of DNA repair [13]. To deal with
DNA damage, cells have evolved a repertoire of cell-cycle check-point and DNA repair
processes. In order to repair DNA damage, four main DNA repair pathways are present
- a simple reversal of the damage; nucleotide excision repair (NER), including mismatch
and transcription-coupled repair; base excision repair (BER); and recombination repair
including nonhomologous end joining [14, 15].
Table 3 shows the 15 DNA repair genes that were present in the list of 1663 significant
genes from Dunckley et al.’s data. It can be seen that the majority of DNA repair genes
have been significantly down-regulated.
Non-homologous end-joining (NHEJ) is the predominant pathway used to repair double-
strand breaks in DNA and is evolutionarily conserved. Polynucleotide kinase 3’-phosphatase
(PNKP) plays an important role in DNA double-strand breaks (DSBs) repair via NHEJ [16].
DSBs are the most lethal form of DNA damage [17]. A role of PNKP in single-strand break
repair, along with DNA polymerase β, DNA ligase I, DNA ligase III and XRCC1, has
also been identified [18, 19]. Deficiency of PNKP results in increased sensitivity to DNA
damaging agents. PNKP is down-regulated in the AD samples by almost 2-fold.
NER is the most important repair process and removes the broadest spectrum of ge-
nomic damages, including UV-induced photoproducts, bulky mono-adducts, cross-links, and
oxidative damage [20]. Several known genetic defects in NER lead to xeroderma pigmento-
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sum, which is associated with a 1000-fold increase in skin cancer as well as a 20-fold increase
in other internal tumors [21]. General transcription factor IIH, polypeptide 1 (GTF2H1),
which is decreased in AD samples by 1.5-fold, is a component of the core-TFIIH basal
transcription factor involved in the NER of DNA [22].
Xeroderma pigmentosum, complementation group c (XPC) is up-regulated by 1.5-fold
and aids in DNA damage recognition and in altering chromatin structure to allow access by
damage-processing enzymes [22]. It recognises various helix-distorting lesions in DNA and
initiates global genome NER. XPC forms a complex with HR23B, XPC-HR23B, and stim-
ulates TDG in the presence of APEX1 [23]. The XPC-HR23B damage-recognition complex
is the earliest damage detector in the NER pathway and is essential for the recruitment
of all subsequent NER factors, including transcription repair factor TFIIH [24]. Rad23
homolog a (RAD23A) (also known as hHR23A) participates in postreplication repair func-
tions [22]. It is down-regulated by 1.3-fold in AD brain samples. RAD23A is involved in
NER through regulation of XPC [25]. Increased levels of RAD23A have been observed in
cells that experience oxidative DNA damage.
ROS attack on DNA leads to a variety of modifications of purine and pyrimidine bases
that are cytotoxic. BER involves four steps, i.e. removal of a damaged base by a DNA
glycosylase, nicking of an apurinic/apyrimidinique (AP) site by AP endonuclease, repair
synthesis, and finally the sealing of the nick by DNA ligase [26]. BER involves remov-
ing the mutated base from the DNA helix and repairing the base with the help of two
main enzymes - DNA glycosylases and AP endonucleases. Specific DNA glycosylases recog-
nise different damaged bases. Uracil-dna glycosylase (UNG) and thymine-dna glycosylase
(TDG) are DNA glycosylases that recognise uracil and thymine, respectively, in DNA caus-
ing its removal [27]. G:U and G:T mispairs in DNA occur by spontaneous deamination of
cytosine and 5-methylcytosine [28, 29]. While UNG is up-regulated by 2.7-fold in the AD
samples, TDG is down-regulated by 2.8-fold. Current evidence has shown that TDG plays
a role in differential gene regulation [30]. Alternative promoter usage and splicing of UNG
results in two different isoforms - the mitochondrial UNG1 and the nuclear UNG2 [31]. A
recent study states that UNG2 may be the sole enzyme for repair of U:A pairs in human
cells and a major glycosylase responsible for repair of G:U mispairs [32]. In the AD samples
UNG2 is down-regulated by 1.7-fold.
The BER pathway initiated by DNA glycosylases prevents mutations by removing the
oxidative lesions from the DNA [33]. However, BER generates genotoxic intermediates,
such as AP sites, which prevent normal DNA replication. Apex nuclease (multifunctional
DNA repair enzyme) 1 (APEX1), which encodes the major AP endonuclease in human cells,
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repairs oxidative DNA damage in a DNA glycosylase-independent manner [34]. It is a mul-
tifunctional enzyme, involved in DNA repair, transcription regulation, oxidative signalling,
etc. APEX1 (also known as Ref-1/HAP-1) is involved in the nucleotide incision repair
(NIR) pathway and is considered as a back-up to the BER pathway for oxidative DNA base
damage [35]. However, since NIR and BER have common substrates, they work in concert
to remove potentially mutagenic and cytotoxic lesions in DNA. APEX1 is hypothesised to
have a role in protection against cell lethality and suppression of mutations [22]. Loss-
of-function studies in mice indicate a critical requirement for APEX1 for animal survival.
It has also been suggested that APEX1 is involved in proofreading, removing mismatched
nucleotides arising from BER polymerases activity [36]. In the AD samples in this study,
APEX1 is decreased by 1.9-fold.
In the AD samples, N-methylpurine-dna glycosylase (MPG), a DNA glycosylase involved
in BER, is decreased by 1.6-fold. It is the first enzyme in BER and recognises and removes
damaged bases, such as 3-methylpurines, 3-methyladenines and 7-methylguanines, leaving
behind an apurinic site that is further processed by other DNA repair proteins [37, 38, 39].
MPG also participates in the repair of 8-hydroxyguanine and hypoxanthine [39]. Cells
deficient in MPG have exhibited increased sensitivity to alkylation-induced chromosome
damage and cell killing [39].
Polymerase (DNA directed), beta (POLB) is another participant of the BER process [32]
and is downregulated by 2.9-fold in the AD individuals. The DNA repair synthesis step in
BER is supported by POLB. In the ‘Passing-the-Baton’ model of BER, BER takes place in
several steps, i.e. the DNA damaged site is transferred from a DNA glycosylase to APEX1,
then from APEX1 to POLB, and finally from POLB to DNA ligase I or III [40]. This
depicts how APEX1 and POLB interact in the BER process. Moreover, APEX1 stimulates
strand-displacement DNA synthesis by POLB [40]. Single-strand DNA interruptions (SSIs)
frequently occur during BER and are rectified by SSI repair subpathways, each mediated
by different genes [41]. Recent work suggests that SSIs produced during the repair of
alkylated DNA bases are repaired by the pathway mediated by POLB [41]. POLB promotes
recruitment of DNA ligase III alpha-XRCC1 to sites of BER and decrease in POLB leads
to a reduced presence of DNA ligase III alpha-XRCC1 at the BER sites [42].
Oxidative DNA demethylation is a mechanism for repairing alkylation damage to DNA.
AlkB (alkylation repair homologues 5 and 6 (e.coli) (ALKBH5 and ALKBH6)) is a gene
involved in this function although its precise function has not yet been resolved. A study has
shown that AlkB is particularly essential for the repair of alkylated single-stranded DNA
(ssDNA) while another has presented evidence that it is a member of the superfamily of
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2-oxoglutarate- and iron-dependent oxygenases (2OG-Fe(II)-oxygenases) [43, 44], thereby
suggesting its functions in the cell. ssDNA is transiently present in the human genome at the
replication fork and at transcription sites. ssDNA is much more vulnerable to the induction
of 1-methyladenine by chemical methylation than double-stranded DNA (dsDNA) [45].
However, since some amount of 1-methyladenine will also be formed by methylation of
dsDNA, AlkB may also be necessary for global genome repair [45]. Numerous different
AlkB homologues exist in human cells [44]. ALKBH6 is down-regulated by 3.2-fold and
ALKBH5 is down-regulated by 1.6-fold in the AD samples of our study.
Fanconi anemia, complementation group g (FANCG) is associated with hypersensitivity
to DNA-damaging agents, chromosomal instability, and defective DNA repair [46]. It is a
part of the RAD6 pathway which is sensitive towards a variety of genotoxic agents. As a
DNA repair protein, it may operate in postreplication repair or in a role of the cell cycle
checkpoint guard [22]. It has also been shown to be involved in protection against oxidative
DNA damage [46]. FANCG is decreased by 1.3-fold. Fanconi anemia, complementation
group f (FANCF) is another gene that is down-regulated by 1.4-fold in AD samples. The
function of FANCF is not well documented. FANCF interacts with FANCG and stimu-
lates the assembly of other FA proteins into a stable core complex [47]. FANCA, FANCC,
FANCE, FANCF, FANCG, and FANCL assemble in a nuclear core complex, which is es-
sential for the monoubiquitination of FANCD2, which in turn co-localises with BRCA1,
RAD51, and PCNA in sites containing other DNA repair proteins [47].
Ribonucleotide reductase m2 b (RRM2B) (also known as p53R2) is reduced by 2-fold in
the AD individuals of our study. The family of ribonucleotide reductase (RR) aids in the
de novo conversion of the ribonucleoside diphosphates to deoxyribonucleoside diphosphates
that are important for DNA synthesis and repair [48]. DNA synthesis is an important phase
of the DNA repair mechanism and RRM2B assembles deoxyribonucleotides for the synthesis
of DNA. P53R2-dependent DNA synthesis is important for cell survival and dysfunction of
this pathway can result in activation of p53-dependent apoptosis [49].
Table 1: Number of significant transcripts obtained at the lowest false discovery rates
achieved by each dataset using SAM and Limma.
Dataset SAM results Limma results
Dunckley 1663 FDR: 0.11% 2 FDR: 1.1E-09%
Blalock 12 FDR: 4.27% 1414 FDR: 0.49%
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Table 2: Some statistically significant biological processes from the set of 1663 significant
genes from Dunckley et al.’s data
GO Biological Process Ease Score
Nervous system development and cellular process 5.93E-08
Homophilic cell adhesion 1.04E-07
Neuron development and cell–cell signaling 3.11E-06
Neurophysiological process and neuron development 2.35E-05
Cell-cell adhesion 7.72E-05
Protein depolymerisation 8.29E-05
Neurogenesis and cell communication 1.91E-04
Neuron maturation and cell differentiation 2.05E-04
Negative regulation of cell organisation and biogenesis and cytoskeleton organisation and biogenesis 3.52E-04
Ion homeostasis and cation transport 0.017
Carbohydrate metabolism and base-excision repair 0.024
DNA repair and carbohydrate metabolism 0.032
Conclusion
The power of microdissected gene expression data and its advantage over regular dissection
gene expression data is evident from this analysis. In both the gene selection methods we
adopted in this study, the Dunckley et al.’s data provided a large number of significant genes
at very low FDR values. Furthermore, In a disease that has cell loss as one of its most sig-
nificant phenotype, microarray data obtained via regular dissection cannot unambiguously
explain whether a transcript was actually down-regulated in a living cell or was not present
due to cell loss. Microarray results validation can be tedious and expensive if measures
are not taken to ensure that the transcripts selected for further investigation are not false
positives. The aforementioned results indicate that although microdissection is expensive,
it provides richer data with less ambiguity in results interpretation. Furthermore, Blalock
et al.’s data does not have incipient AD cases as the samples are of Braak stage V AD, and
therefore may be an inappropriate dataset to study incipient AD.
AD has been characterised by extensive cell death. Cell death can occur by injury
(necrosis) or by suicide (apoptosis). Sometimes cells are induced to commit suicide in
order to preserve genomic integrity. Two factors induce a cell to commit suicide - the
withdrawal of positive signals, that is, signals needed for continued survival, and the receipt
of negative signals. Positive signals include growth factors for neurons, and negative signals
include increased levels of oxidants within the cell, DNA damage by these oxidants and the
accumulation of misfolded proteins. In AD brains the negative signals clearly overshadow
the positive signals. When defenses against DNA damage cannot keep pace with the degree
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Table 3: Fifteen DNA repair genes identified from Dunckley et al.’s data. All but two genes
are downregulated.
RefSeq ID Gene name Fold Change
NM 001641 apex nuclease (multifunctional dna repair enzyme) 1 -1.90
NM 002690 polymerase (DNA directed), beta -2.85
NM 003211 thymine-dna glycosylase -2.83
NM 004628 xeroderma pigmentosum, complementation group c 1.46
NM 004629 fanconi anemia, complementation group g -1.34
NM 005053 rad23 homolog a (s. cerevisiae) -1.31
NM 005316 general transcription factor IIH, polypeptide 1, 62kda -1.45
NM 007254 polynucleotide kinase 3’-phosphatase -1.95
NM 015713 ribonucleotide reductase m2 b (tp53 inducible) -2.04
NM 022725 fanconi anemia, complementation group f -1.42
NM 003362 uracil-dna glycosylase 2.75
NM 001024592 uracil-dna glycosylase 2 -1.68
NM 001015052 n-methylpurine-dna glycosylase -1.59
NM 017758 alkb, alkylation repair homolog 5 (e. coli) -1.56
NM 032878 alkb, alkylation repair homolog 6(e. coli) -3.16
of damage, such as under conditions of high oxidative or alkylating stress, or when repair is
inefficient, the miscoding potential of DNA lesions can result in the accumulation of genetic
defects that may contribute to early senescence, apoptosis or cancer. Therefore, DNA repair
rate is an important determinant of cell pathology [27].
The rate of oxidative DNA damage is elevated in the brain due to the high oxygen
consumption rate and the BER pathway is the key player in oxidative DNA damage re-
pair [50]. Furthermore, DNA POLB is hypothesised to be the major player in defective
repair in ageing brains [51]. In line with the aforementioned findings, we have noticed the
increased presence of genes involved in the BER pathway, many of which have been down-
regulated in AD samples. Some of the 15 DNA repair genes present in our significant gene
list are involved in the early stages of DNA damage detection and some of them help in the
recruitment of other downstream proteins to help in DNA repair. In summary, our results
indicate that the base excision repair pathway fails to handle the DNA damage repair in
an efficient manner and is a compelling explanation for many of the pathological features
of LOAD.
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Materials and Methods
Data
Dunckley et al. dataset consists of 13 normal controls (Braak stages 0–II; average age: 80.1
years) and 20 AD affected (Braak stages III–IV; average age: 84.7 years) samples obtained
by laser capture microdissection (LCM) from the entorhinal cortex [7]. Braak stages III–
IV is considered ‘incipient’ AD [2, 10]. In Dunckley et al.’s dataset, 1000 neurons were
collected from each of the 33 samples via LCM. Blalock et al. dataset consists of 9 nor-
mal controls (Braak stage II; average age: 85.3 years) and 22 AD affected (Braak stages
V–VI; average age: 85.8 years) samples generated by regular dissection of hippocampal
specimens (CA1 and CA3) [6]. The patients were classified as ‘incipient’ based on their
MiniMental Status Examination (MMSE) scores. Both datasets consisted of affected sam-
ples that showed the NFT pathological phenotype. Moreover, both datasets used Affymetrix
GeneChip HGU133A for their gene expression profiling. Each dataset was analysed sepa-
rately.
Significant transcripts selection
Both datasets were normalised using gcRMA [52]. Probesets were mapped to genes using
DAVID [22]. Probesets that did not map to any gene name and those matching to hy-
pothetical proteins with no known functions, at the time of writing this manuscript, were
removed. When multiple probesets mapped to the same gene, only the probeset with the
highest mean was selected. This preprocessing resulted in a total of 15827 transcripts for
Dunckley et al.’s data and 11955 transcripts for Blalock’s et al.’s data.
In order to compare the power of both datasets in terms of the lowest false discovery
rate (FDR) and number of differentially expressed transcripts, we applied two different dif-
ferentially expressed genes selection methods on the two datasets - SAM [8] and Limma [9].
SAM is an open-source software which uses a modified t-statistics approach to identify
differentially expressed genes. Limma is a software package(http://www.bioconductor.org)
consisting of various linear models to select differentially expressed genes. We used the
linear model that uses t-statistics and an empirical Bayes approach to select significant
genes.
First SAM and Limma were applied to both datasets, and the FDR and number of
significant genes were recorded and results compared. Then the DNA repair genes present
in the list of differentially expressed genes obtained from Dunckley et al.’s data was taken
11
to investigate the DNA repair capacity in incipient AD. DNA repair genes were identified
by comparing to the genes obtained with those described in a published article on DNA
repair [31] and DAVID [22]. When Gene Ontology (GO) analysis was performed using EASE
(http://niaid.abcc.ncifcrf.gov/home.jsp) on the complete list of significant genes identified
by SAM from Dunckley et al.’s data, the DNA repair category was found to be statistically
significant. For the sake of brevity, we did not include the analysis of significant genes
obtained from limma.
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